Vitura Health Ltd (VIT) - Net Assets
Based on the latest financial reports, Vitura Health Ltd (VIT) has net assets worth AU$45.36 Million AUD (≈ $32.10 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$76.85 Million ≈ $54.38 Million USD) and total liabilities (AU$31.49 Million ≈ $22.28 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Vitura Health Ltd's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$45.36 Million |
| % of Total Assets | 59.02% |
| Annual Growth Rate | N/A |
| 5-Year Change | 416.14% |
| 10-Year Change | N/A |
| Growth Volatility | 7327.4 |
Vitura Health Ltd - Net Assets Trend (2017–2025)
This chart illustrates how Vitura Health Ltd's net assets have evolved over time, based on quarterly financial data. Also explore VIT current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Vitura Health Ltd (2017–2025)
The table below shows the annual net assets of Vitura Health Ltd from 2017 to 2025. For live valuation and market cap data, see Vitura Health Ltd (VIT) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$47.60 Million ≈ $33.68 Million |
+23.82% |
| 2024-06-30 | AU$38.44 Million ≈ $27.20 Million |
+10.15% |
| 2023-06-30 | AU$34.90 Million ≈ $24.70 Million |
+33.85% |
| 2022-06-30 | AU$26.07 Million ≈ $18.45 Million |
+182.73% |
| 2021-06-30 | AU$9.22 Million ≈ $6.53 Million |
-31.67% |
| 2020-06-30 | AU$13.50 Million ≈ $9.55 Million |
-5.07% |
| 2019-06-30 | AU$14.22 Million ≈ $10.06 Million |
+20974.63% |
| 2018-06-30 | AU$67.47K ≈ $47.74K |
+403.61% |
| 2017-06-30 | AU$-22.22K ≈ $-15.72K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Vitura Health Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1601937700.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | AU$16.00 Million | 33.19% |
| Common Stock | AU$36.93 Million | 76.62% |
| Other Comprehensive Income | AU$-4.73 Million | -9.81% |
| Total Equity | AU$48.20 Million | 100.00% |
Vitura Health Ltd Competitors by Market Cap
The table below lists competitors of Vitura Health Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kamdhenu Ventures Limited
NSE:KAMOPAINTS
|
$18.29 Million |
|
Muar Ban Lee Group Bhd
KLSE:5152
|
$18.30 Million |
|
Ion Video Ltd
AU:IOV
|
$18.30 Million |
|
SAF Tehnika A/S
F:VTZ
|
$18.30 Million |
|
IXUP Ltd
AU:IXU
|
$18.29 Million |
|
Cliq Digital AG
F:CLIQ
|
$18.28 Million |
|
Rackla Metals Inc
V:RAK
|
$18.27 Million |
|
Kritika Wires Limited
NSE:KRITIKA
|
$18.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vitura Health Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 38,784,091 to 48,203,024, a change of 9,418,933 (24.3%).
- Net income of 3,324,321 contributed positively to equity growth.
- Share repurchases of 25,771 reduced equity.
- New share issuances of 5,171,196 increased equity.
- Other comprehensive income decreased equity by 50,836.
- Other factors increased equity by 1,000,023.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$3.32 Million | +6.9% |
| Share Repurchases | AU$25.77K | -0.05% |
| Share Issuances | AU$5.17 Million | +10.73% |
| Other Comprehensive Income | AU$-50.84K | -0.11% |
| Other Changes | AU$1.00 Million | +2.07% |
| Total Change | AU$- | 24.29% |
Book Value vs Market Value Analysis
This analysis compares Vitura Health Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.49x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | AU$0.00 | AU$0.04 | x |
| 2018-06-30 | AU$0.00 | AU$0.04 | x |
| 2019-06-30 | AU$0.11 | AU$0.04 | x |
| 2020-06-30 | AU$0.15 | AU$0.04 | x |
| 2021-06-30 | AU$0.02 | AU$0.04 | x |
| 2022-06-30 | AU$0.05 | AU$0.04 | x |
| 2023-06-30 | AU$0.06 | AU$0.04 | x |
| 2024-06-30 | AU$0.07 | AU$0.04 | x |
| 2025-06-30 | AU$0.08 | AU$0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Vitura Health Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.90%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.68%
- • Asset Turnover: 1.64x
- • Equity Multiplier: 1.57x
- Recent ROE (6.90%) is below the historical average (23.12%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.00% | -124.12% | 14.73x | 0.00x | AU$-20.12K |
| 2018 | 222.85% | 33.59% | 1.45x | 4.57x | AU$143.60K |
| 2019 | -20.50% | 0.00% | 0.00x | 1.26x | AU$-4.34 Million |
| 2020 | -29.29% | -3179.02% | 0.01x | 1.21x | AU$-5.28 Million |
| 2021 | -43.56% | -18.65% | 1.71x | 1.36x | AU$-4.98 Million |
| 2022 | 23.17% | 9.03% | 1.56x | 1.64x | AU$3.44 Million |
| 2023 | 39.48% | 11.77% | 2.50x | 1.34x | AU$10.31 Million |
| 2024 | 9.06% | 2.84% | 1.74x | 1.84x | AU$-366.03K |
| 2025 | 6.90% | 2.68% | 1.64x | 1.57x | AU$-1.50 Million |
Industry Comparison
This section compares Vitura Health Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $29,670,098
- Average return on equity (ROE) among peers: 4903.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Vitura Health Ltd (VIT) | AU$45.36 Million | 0.00% | 0.69x | $18.29 Million |
| Althea Group Holdings Ltd (AGH) | $41.45 Million | -29.25% | 0.36x | $12.05 Million |
| BOD Science Ltd (BOD) | $3.47 Million | -155.95% | 0.53x | $3.01 Million |
| BPH Global Ltd (BP8) | $149.84K | 50079.24% | 22.90x | $2.62 Million |
| Cann Group Ltd (CAN) | $648.33K | -644.19% | 0.12x | $5.62 Million |
| ECS Botanics Holdings Ltd (ECS) | $319.74K | -109.87% | 0.16x | $5.65 Million |
| Ecofibre Ltd (EOF) | $109.94 Million | -13.34% | 0.36x | $5.36 Million |
| Epsilon Healthcare Ltd (EPN) | $2.99 Million | -68.61% | 4.98x | $5.51 Million |
| Elixinol Wellness Ltd (EXL) | $99.42 Million | 0.00% | 0.04x | $2.05 Million |
| IDT Australia Ltd (IDT) | $32.86 Million | 21.64% | 0.29x | $12.10 Million |
| Invion Ltd (IVX) | $5.46 Million | -46.66% | 0.11x | $3.70 Million |
About Vitura Health Ltd
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual h… Read more